Acasti Pharma is on the Cruelty Free Investing animal use list due to its employment of animal testing in pharmaceutical product development and testing.
2015 Company press release referencing the use of animal testing: https://www.firstwordpharma.com/node/986658?tsid=17
2015 Annual Report: http://www.acastipharma.com/wp-content/uploads/Acasti-2015-AIF.pdf
Acasti Pharma is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre®, for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one-third of the U.S. population. http://www.acastipharma.com